Matt Quinn, Ph.D.

As a scientific consultant at Womble Bond Dickinson, Matt provides strategic solutions to clients and attorneys operating within the life science and pharmaceutical sectors to meet their objectives. With over 15 years of biomedical research experience in academic and government settings, Matt focuses his consulting practice on working with academic medical centers and startups to commercialize and market their scientific discoveries. To achieve this, Matt provides clients and attorneys with a range of services including strategy consulting, medical writing deliverables (scientific manuscripts, corporate white papers, clinical study reports, and grants), and market landscape analysis. Additionally, Matt works with regulatory scientists and patent attorneys and agents to ensure his client’s assets are compliant with federal regulatory agencies and that their intellectual property are protected. Matt also consults with attorneys to support litigation work at Womble Bond Dickinson. This includes distilling complex medical literature to aid attorneys with their defense against medical claims and consulting with attorneys developing scientific strategies for defense as well as challenging the scientific basis of plaintiff’s claims. Matt also is involved in the vetting of expert witnesses and their scientific statements.

Matt received his Ph.D. in Medical Sciences with a focus in molecular and cellular biology from Texas A&M Health Sciences Center followed by a postdoctoral fellowship in molecular endocrinology at the National Institute of Health in Research Triangle Park, North Carolina. Prior to joining Womble in 2024, Matt was an Assistant Professor in the department of Pathology and Internal Medicine at Wake Forest University School of Medicine where he was the director of an independent lab aimed at studying the metabolic effects of inflammation and infection. During this time, Matt mentored junior scientists and served as the primary advisor for a Ph.D. student’s thesis committee. He has authored more than 40 peer reviewed scientific publications and serves on the editorial board for several scientific journals.